Intensive blood pressure lowering: a practical review

Miguel Camafort, Josep Redón, Wook Bum Pyun, Antonio Coca

Research output: Contribution to journalReview articlepeer-review

14 Scopus citations


According to the last Hypertension guideline recommendations, it may be concluded that intensive BP lowering is only advisable in a subgroup of patients where there is a clear net benefit of targeting to lower BP goals. However, taking into account the relevance of correct BP measurement, estimates of the benefits versus the harm should be based on reliable office BP measurements and home BP measurements. There is still debate about which BP goals are optimal in reducing morbidity and mortality in uncomplicated hypertensives and in those with associated comorbidities. In recent years, trials and meta-analyses have assessed intensive BP lowering, with some success. However, a careful examination of the results shows that current data are not easily applicable to the general hypertensive population. This article reviews the evidence on and controversies about intensive BP lowering in general and in specific clinical situations, and the importance of obtaining reliable BP readings in patients with hypertension and comorbidities.

Original languageEnglish
Article number21
JournalClinical Hypertension
Issue number1
StatePublished - 1 Dec 2020

Bibliographical note

Publisher Copyright:
© 2020, The Author(s).


  • Ageing
  • Ambulatory blood pressure measurement
  • Chronic kidney disease
  • Diabetes mellitus type 2
  • Heart failure
  • Intensive blood pressure lowering
  • Ischemic heart disease
  • Obesity, cardiovascular risk


Dive into the research topics of 'Intensive blood pressure lowering: a practical review'. Together they form a unique fingerprint.

Cite this